Skip to main content
Premium Trial:

Request an Annual Quote

Natera Snags Prenatal Test Distributor for Spain

NEW YORK (GenomeWeb News) – The prenatal genetic testing firm Natera said today that it has signed up Echevarne, a clinical analysis lab based in Barcelona, to offer its non-invasive prenatal screening test for chromosomal abnormalities to customers in Spain.

Under the distribution agreement, Echevarne's lab will offer the Natera Panorama test, which identifies trisomies 13, 18, and 21, as well as some sex chromosome abnormalities, to detect disorders like Down, Patau, Edwards, and Turner syndromes.

The blood-based Panorama test, which Natera launched in March, examines cell-free DNA and uses the company's NATUS algorithm to analyze 19,500 SNPs isolated from the mother's blood.

The company said the test has a 99 percent or greater sensitivity for trisomies 13, 18, and 21, and it can be performed as early as nine weeks into pregnancy.

Echevarne has facilities in hospital labs across Spain and in Portugal.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.